Bcr-Abl Overview
Cat No. | Product Name | CAS No. | Purity | Order |
---|---|---|---|---|
I035855 | S116836 | 1257628-57-1 | 98.0% | Inquiry |
I019044 | CHMFL-ABL-121 | 2270879-07-5 | ≥ 95% | Inquiry |
I018785 | CHMFL-ABL/KIT-155 | 2081093-21-0 | ≥ 95% | Inquiry |
I017425 | Ponatinib D8 | 1562993-37-6 | ≥ 95% | Inquiry |
I017480 | Imatinib D4 | 1134803-16-9 | ≥ 95% | Inquiry |
I015341 | HG-7-85-01 | 1258391-13-7 | ≥ 95% | Inquiry |
I008826 | Ponatinib | 943319-70-8 (free base) | ≥ 95% | Inquiry |
I008827 | Ponatinib HCl | 1114544-31-8 (HCl) | ≥ 95% | Inquiry |
I008294 | Nilotinib free base | 641571-10-0 (free base) | ≥ 95% | Inquiry |
I008295 | Nilotinib HCl hydrate | 923288-90-8 (HCl hydrate) | ≥ 95% | Inquiry |
I007276 | Imatinib free base | 152459-95-5 (free base) | ≥ 95% | Inquiry |
I003901 | Bafetinib | 859212-16-1 (or 887650-05-7) | ≥ 95% | Inquiry |
I005492 | Nilotinib monohydrochloride monohydrate | 923288-90-8 | ≥ 95% | Inquiry |
I005127 | Dasatinib hydrochloride | 854001-07-3 | ≥ 95% | Inquiry |
I005159 | Bafetinib | 859212-16-1 | ≥ 95% | Inquiry |
I004864 | GNF-2 | 778270-11-4 | ≥ 95% | Inquiry |
I002889 | PD173955 | 260415-63-2 | ≥ 95% | Inquiry |
I000144 | DCC-2036 | 1020172-07-9 | ≥ 95% | Inquiry |
R062076 | PD 180970 | 287204-45-9 | ≥ 95% | Inquiry |
R045026 | Imatinib-d8 | 1092942-82-9 | ≥ 95% | Inquiry |
R043870 | Nilotinib-d6 | 1268356-17-7 | ≥ 95% | Inquiry |
R009977 | Nilotinib-d3 | 1215678-43-5 | ≥ 95% | Inquiry |
R008222 | Dasatinib-d8 | 1132093-70-9 | ≥ 95% | Inquiry |
A000113 | Dasatinib Monohydrate | 863127-77-9 | ≥ 95% | Inquiry |
A000288 | Dasatinib (BMS-354825, Sprycel) | 302962-49-8 | ≥ 95% | Inquiry |